NCT04102995 - A Study Investigating the Efficacy and Safety of Sepranolone in Women With Menstrual Migraine | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 27, 2019

Primary Completion Date

May 15, 2021

Study Completion Date

May 15, 2021

Conditions

Menstrual Migraine

Interventions

DRUG

Sepranolone injection low dose

Subcutaneous (SC) administration

DRUG

Sepranolone injection high dose

Subcutaneous (SC) administration

DRUG

Placebo injection

Subcutaneous (SC) administration

Trial Locations (7)

ProbarE i Lund, Lund

Suomen Terveystalo Plc, Helsinki

Suomen Terveystalo Plc, Tampere

Suomen Terveystalo Plc, Turku

CTC Clinical Trial Center, Gothenburg

Karolinska Trial Alliance, Stockholm

CTC Clinical Trial Consultants, Uppsala